(ARDT) Ardent Health Partners - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03980N1072
ARDT: Hospitals, Clinics, Medical Services, Telehealth, Ambulatory Care, Emergency Services, Diagnostic Imaging
Ardent Health Partners, Inc. (NYSE:ARDT) operates a diverse network of healthcare facilities across the United States, delivering comprehensive medical services through its hospitals, clinics, and telehealth platforms. The company provides a broad spectrum of care, including general and specialty services such as cardiology, oncology, orthopedics, and womens health, across both inpatient and ambulatory settings. Its ambulatory network encompasses primary and specialty care clinics, ambulatory surgery centers, urgent care facilities, free-standing emergency departments, and diagnostic imaging centers. Ardent also manages acute care hospitals, rehabilitation centers, and surgical hospitals, ensuring a continuum of care for patients. Founded in 2001 and headquartered in Brentwood, Tennessee, the company is a subsidiary of EGI-AM Investments, L.L.C., and is recognized for its commitment to quality patient outcomes and operational efficiency.
Based on current
Additional Sources for ARDT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ARDT Stock Overview
Market Cap in USD | 2,591m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2024-07-18 |
ARDT Stock Ratings
Growth Rating | -49.7 |
Fundamental | 57.3 |
Dividend Rating | 0.0 |
Rel. Strength | -17.8 |
Analysts | 4.4/5 |
Fair Price Momentum | 11.05 USD |
Fair Price DCF | 19.26 USD |
ARDT Dividends
No Dividends PaidARDT Growth Ratios
Growth Correlation 3m | -89.2% |
Growth Correlation 12m | -82.4% |
Growth Correlation 5y | -82.4% |
CAGR 5y | -21.23% |
CAGR/Max DD 5y | -0.50 |
Sharpe Ratio 12m | -0.09 |
Alpha | -26.68 |
Beta | 0.212 |
Volatility | 53.98% |
Current Volume | 143.7k |
Average Volume 20d | 317.2k |
As of April 30, 2025, the stock is trading at USD 12.65 with a total of 143,664 shares traded.
Over the past week, the price has changed by +7.11%, over one month by -8.00%, over three months by -13.95% and over the past year by -21.23%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.28 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of April 2025 is 11.05. This means that ARDT is currently overvalued and has a potential downside of -12.65%.
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
- Strong Buy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 11.9 in April 2026. The stock is currently trading at 12.65. This means that the stock has a potential downside of -5.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 22.8 | 80.1% |
Analysts Target Price | 22.8 | 80.1% |
ValueRay Target Price | 11.9 | -5.7% |